Product Information
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by Accord Healthcare Inc., priced at $0.6746 per EA under NDC 16729004301. Its NADAC has been published 643 times since Nov 28, 2013.
FDA first approved this application on Aug 31, 2011. Its Orange Book therapeutic-equivalence code is BX.
Strength
5 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729004301
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA091195FDA Approved
8/31/2011
TE Code
BX
On Market Since
9/30/2011
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has been published 643 times since Nov 28, 2013, and over the history we have for it it has declined 93.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6746 per EA |
|---|---|
| All-time high | $11.2888 (Dec 10, 2014) |
| All-time low | $0.6713 (Apr 22, 2026) |
| 52-week high | $0.8637 |
| 52-week low | $0.6713 |
| Median price | $2.0759 |
| Average price | $3.0757 |
| Largest weekly change | +172.0% (Dec 13, 2017) |
| Weeks tracked | 643 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
-4.8%
1Y
-21.9%
3Y
-57.2%
5Y
-52.4%
All
-93.1%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by Accord Healthcare Inc., is $0.6746 per EA (NDC 16729004301), effective May 20, 2026.
How has the price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has declined 93.1%. It has been tracked across 643 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Nov 28, 2013, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.6713 (Apr 22, 2026) to a high of $11.2888 (Dec 10, 2014), with a median of $2.0759 per EA.
Are there cheaper alternatives to TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), is $0.6591 per EA — about 2% below TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE).
Who manufactures TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 16729004301) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.